AAAAAA

   
Results: 1-9 |
Results: 9
PHASE-I STUDY OF PHARMACOLOGICALLY BASED DOSING OF CARBOPLATIN WITH FILGRASTIM SUPPORT IN WOMEN WITH EPITHELIAL OVARIAN-CANCER
Authors: LIND MJ GHAZALASWAD S GUMBRELL L FISHWICK K CRAIGS D MILLWARD MJ BAILEY NP DOREGREEN F CHAPMAN F SIMMONS D PROCTOR M OAKEY A ROBSON L MIDDLETON I MCCANN E SINHA D CALVERT AH
Citation: Mj. Lind et al., PHASE-I STUDY OF PHARMACOLOGICALLY BASED DOSING OF CARBOPLATIN WITH FILGRASTIM SUPPORT IN WOMEN WITH EPITHELIAL OVARIAN-CANCER, Journal of clinical oncology, 14(3), 1996, pp. 800-805
A PHASE-I CLINICAL-STUDY OF THE ANTIPURINE ANTIFOLATE LOMETREXOL (DDATHF) GIVEN WITH ORAL FOLIC-ACID
Authors: LAOHAVINIJ S WEDGE SR LIND MJ BAILEY N HUMPHREY A PROCTOR M CHAPMAN F SIMMONS D OAKLEY A ROBSON L GUMBRELL L TAYLOR GA THOMAS HD BODDY AV NEWELL DR CALVERT AH
Citation: S. Laohavinij et al., A PHASE-I CLINICAL-STUDY OF THE ANTIPURINE ANTIFOLATE LOMETREXOL (DDATHF) GIVEN WITH ORAL FOLIC-ACID, Investigational new drugs, 14(3), 1996, pp. 325-335
PHASE-I AND PHARMACOKINETIC STUDY OF A WATER-SOLUBLE ETOPOSIDE PRODRUG, ETOPOSIDE PHOSPHATE (BMY-40481)
Authors: MILLWARD MJ NEWELL DR MUMMANENI V IGWEMEZIE LN BALMANNO K CHARLTON CJ GUMBRELL L LIND MJ CHAPMAN F PROCTOR M SIMMONDS D CANTWELL BMJ TAYLOR GA MCDANIEL C WINOGRAD B KAUL S BARBAIYA RH CALVERT AH
Citation: Mj. Millward et al., PHASE-I AND PHARMACOKINETIC STUDY OF A WATER-SOLUBLE ETOPOSIDE PRODRUG, ETOPOSIDE PHOSPHATE (BMY-40481), European journal of cancer, 31A(13-14), 1995, pp. 2409-2411
PHARMACOKINETICS AND PHARMACODYNAMICS OF PROLONGED ORAL ETOPOSIDE IN WOMEN WITH METASTATIC BREAST-CANCER
Authors: MILLWARD MJ NEWELL DR YUEN K MATTHEWS JP BALMANNO K CHARLTON CJ GUMBRELL L LIND MJ CHAPMAN F PROCTOR M SIMMONDS D CANTWELL BMJ CALVERT AH
Citation: Mj. Millward et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF PROLONGED ORAL ETOPOSIDE IN WOMEN WITH METASTATIC BREAST-CANCER, Cancer chemotherapy and pharmacology, 37(1-2), 1995, pp. 161-167
CARBOPLATIN IN COMBINATION WITH PACLITAXEL IN ADVANCED OVARIAN-CANCER- DOSE DETERMINATION AND PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS
Authors: CALVERT AH BODDY A BAILEY NP SIDDIQUI N HUMPHREYS A HUGHES A ROBSON L GUMBRELL L THOMAS H CHAPMAN F PROCTOR M SIMMONS D OAKEY A LIND MJ SINHA DV NEWELL DR
Citation: Ah. Calvert et al., CARBOPLATIN IN COMBINATION WITH PACLITAXEL IN ADVANCED OVARIAN-CANCER- DOSE DETERMINATION AND PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS, Seminars in oncology, 22(5), 1995, pp. 91-98
THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR TO DELIVER 4 CYCLES OF IFOSFAMIDE AND EPIRUBICIN EVERY 14 DAYS IN WOMEN WITH ADVANCED OR METASTATIC BREAST-CANCER
Authors: LIND MJ GUMBRELL L CANTWELL BMJ MILLWARD MJ SIMMONDS D PROCTOR M CHAPMAN F MCCANN E MIDDLETON I CALVERT AH
Citation: Mj. Lind et al., THE USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR TO DELIVER 4 CYCLES OF IFOSFAMIDE AND EPIRUBICIN EVERY 14 DAYS IN WOMEN WITH ADVANCED OR METASTATIC BREAST-CANCER, British Journal of Cancer, 71(3), 1995, pp. 610-613
RESULTS OF CHEMOTHERAPY USING IFOSFAMIDE WITH DOXORUBICIN IN ADVANCEDBREAST-CANCER
Authors: MILLWARD M LIND M GUMBRELL L ROBINSON A LENNARD T CANTWELL B
Citation: M. Millward et al., RESULTS OF CHEMOTHERAPY USING IFOSFAMIDE WITH DOXORUBICIN IN ADVANCEDBREAST-CANCER, Breast cancer research and treatment, 29(3), 1994, pp. 271-277
CARBOPLATIN AND GRANULOCYTE-COLONY-STIMULATING FACTOR AS FIRST-LINE TREATMENT FOR EPITHELIAL OVARIAN-CANCER - A PHASE-I DOSE-INTENSITY ESCALATION STUDY
Authors: CALVERT AH LIND MJ GHAZALASWAD S GUMBRELL L MILLWARD MJ BAILEY NP DOREGREEN F CHAPMAN F SIMMONS D PROCTOR M OAKEY A SINHA DP MCCANN E MIDDLETON I
Citation: Ah. Calvert et al., CARBOPLATIN AND GRANULOCYTE-COLONY-STIMULATING FACTOR AS FIRST-LINE TREATMENT FOR EPITHELIAL OVARIAN-CANCER - A PHASE-I DOSE-INTENSITY ESCALATION STUDY, Seminars in oncology, 21(5), 1994, pp. 1-6
LONG-TERM ORAL ETOPOSIDE IN METASTATIC BREAST-CANCER - CLINICAL AND PHARMACOKINETIC RESULTS
Authors: CALVERT AH LIND MJ MILLWARD MM CANTWELL BMJ GUMBRELL L PROCTOR M SIMMONS D CHAPMAN F ROBINSON A CHARLTON C BALMANNO K NEWELL D
Citation: Ah. Calvert et al., LONG-TERM ORAL ETOPOSIDE IN METASTATIC BREAST-CANCER - CLINICAL AND PHARMACOKINETIC RESULTS, Cancer treatment reviews, 19, 1993, pp. 27-33
Risultati: 1-9 |